A1M Pharma Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Tobias Larsson Agervald, was filed 27 Dec 2019.
A1M Pharma: what insiders have been doing
A1M Pharma is a listed company. Its directors and officers file their transactions with Finansinspektionen. A1M Pharma has had no insider filing for more than a year; the last one goes back to 27 December 2019.
Over the whole record (from 2017), the tally stands at 5 purchases and no sales.
Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Financial data
· cache
- 2,105,263 shares@ SEK 0.19100.0% of flowSyntetisk optionFI:csv-8c7dc7f52e5eb07eb9fbCanonical exit: 13 May 2019 (T+90)
- 30,009 shares@ SEK 1.80100.0% of flowAktieISIN SE0009973357FI:csv-596d0e4083858a11bb88Canonical exit: 27 Nov 2019 (T+90)
- 49,020 shares@ SEK 10.20100.0% of flowBTU (betald tecknad unit)ISIN SE0012230720FI:csv-e2530408f033d270c069
- 147,060 shares0TeckningsrättISIN SE0012230712FI:csv-9e4d8ff418e9e8495a19Canonical exit: 16 May 2019 (T+90)
- 500,004 sharesBTU (betald tecknad unit)ISIN SE0012230720FI:csv-c2a9db2e85bd9110f2df
- 1,000 shares@ SEK 15.0053.1% of flowISIN SE0009773450FI:csv-b3db882473af50eca9c4
- 1,277 shares@ SEK 9.9946.9% of flowISIN SE0005876828FI:csv-c3c385d004a82395d5f6Canonical exit: 17 Jan 2018 (T+90)
- 51,396.75 shares@ SEK 0.75100.0% of flowISIN SE0005876828FI:csv-096472be9229cea159dbCanonical exit: 13 Jul 2017 (T+90)
8 of 8 declarations
About A1M Pharma
A1M Pharma is a biopharmaceutical company focused on developing treatments for serious diseases. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations